A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
Seagen Inc.
Seagen Inc.
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Medical College of Wisconsin
Baylor College of Medicine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Ohio State University Comprehensive Cancer Center
Boehringer Ingelheim
Ruijin Hospital
Stanford University
Children's Oncology Group
University of Nebraska
Tessa Therapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Children's Hospital Medical Center, Cincinnati
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Novartis
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
Mayo Clinic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Immune Cell, Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Progen Pharmaceuticals
Morphotek
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)